Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Bruker to acquire Michrom Bioresources

Bruker today announced that it has signed an agreement to acquire Michrom Bioresources, Inc., a 20 year old, privately owned company based in Auburn, California. Michrom provides liquid chromatography instrumentation, accessories, and consumables for applications in the life science, chemical and applied markets.

24 Feb 2011

Australia’s top scientist takes on top job

Today, the man who is known for one of Australia’s greatest medical achievements – the development of a cervical cancer vaccine – has been appointed as Chief Executive Officer of the Translational Research Institute (TRI) in Brisbane, Queensland.

23 Feb 2011

Survey: 67% of pharma and biotech companies outsource more than half of all clinical trials

Driving clinical development and speeding time to market through effective relationship management will be two of the key themes discussed at Pharma IQ's 2nd Annual Global Clinical Outsourcing Forum this May.

23 Feb 2011

MWV announces availability of preservative pharmaceutical spray pumps for sampling

MeadWestvaco Corp. announced today the availability of its Preservative Free Pump Topical for sampling. This product, specifically engineered for topical applications, is the most recent innovation in its portfolio of preservative free pharmaceutical spray pumps. The new pump will be featured at Pharmapack 2011, in Paris, France from February 23-24.

23 Feb 2011

FDA refuses Delcath's chemosaturation delivery system NDA filing

Delcath Systems, Inc. announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration for the New Drug Application for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.

22 Feb 2011

CARBOGEN AMCIS installs new stability chambers at Switzerland facility

Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has expanded its service portfolio and capacity for stability studies. In compliance with the latest International Conference on Harmonisation (ICH) guidelines, and in response to customer demand, the company has installed new stability chambers at the Hunzenschwil (Neuland), Switzerland operations and offers short-term, long-term, accelerated, intermediate, follow-up and customized tests.

21 Feb 2011

Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolio

Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for recombinant insulin manufactured by global Indian biotech Wockhardt. According to estimates, the potential in cell culture markets is around US$ 50 million.

21 Feb 2011

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Australian health care company Prima BioMed Ltd announced today that there has been an agreement for strategy and design of the Phase III clinical registration trial for the CVac™ immunotherapy therapeutic ovarian cancer vaccine.

19 Feb 2011

Novavax announces final safety, immunogenicity results from H1N1 VLP vaccine at WHO meeting

Novavax, a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th World Health Organization Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials.

19 Feb 2011

China-Biotics applies 5 new patents for probiotics supplement, preparation

China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced it has applied for 5 new patents through its wholly owned subsidiary Growing Bioengineering to the State Bureau of Intellectual Property.

18 Feb 2011

San Francisco area patient files DePuy hip replacement recall lawsuit

Wendy R. Fleishman, a partner in the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, announces that Alec MacPhail, of Danville, California, has filed a personal injury lawsuit against DePuy Orthopedics, Inc., and its parent company, Johnson & Johnson, Inc., for manufacturing an allegedly defective prosthetic hip implant device sold under the brand name DePuy ASR XL Acetabular System.

18 Feb 2011

Inspire announces strategic corporate restructuring on its eye care business

Inspire Pharmaceuticals, announced today a strategic corporate restructuring designed to result in the Company focusing activities on its eye care business, allowing it to fully leverage existing commercial capabilities, pipeline assets and related corporate development and licensing opportunities.

17 Feb 2011

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2010.

17 Feb 2011

Spectranetics fourth quarter revenues decrease 1% to $29.3 million

Spectranetics Corporation today reported financial results for the quarter and full year ended December 31, 2010.

17 Feb 2011

Poll: 73% of New Jersey people think investment on global health research is important to state's economy

Despite the unpredictable economy, nearly three-quarters of New Jersey residents think spending money on research to improve health globally is important to jobs and incomes in the state, according to a new statewide poll commissioned by Research!America.

17 Feb 2011

Avesthagen completes development of microalgae based vegetarian DHA omega 3 essential fatty acid

Avesthagen Limited announced completion of a landmark project for the development of AvestaDHA(TM) - a vegetarian source of DHA (docohexanoic acid) omega 3 essential fatty acid based on an innovative approach using naturally occurring microalgae.

17 Feb 2011

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.

17 Feb 2011

Bruker introduces NPFLEX-LA non-contact, three-dimensional surface metrology system

Bruker Corporation announced today the NPFLEX-LA™, the first non-contact, three-dimensional surface metrology system to provide quantitative lead angle and surface texture measurements for the control and reduction of fluid leakage of rotary dynamic sealing surfaces.

16 Feb 2011

BARDA awards contracts for development of drugs to treat injuries associated with acute radiation syndrome

Two contracts for advanced development of drugs to treat skin and lung injuries associated with acute radiation syndrome (ARS) were awarded this week by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA). These contracts are the first by BARDA to address the skin and lung injuries that arise from acute exposure to high levels of ionizing radiation - the type of radiation that results from a nuclear blast.

16 Feb 2011

Research: Plants may assist in detecting environmental contaminants, explosives

Someday, that potted palm in your living room might go from green to white, alerting you to a variety of nasty contaminants in the air, perhaps even explosives.

16 Feb 2011

Manufacturing News and Research

Further Reading

Bruker to acquire Michrom Bioresources

Australia’s top scientist takes on top job

Survey: 67% of pharma and biotech companies outsource more than half of all clinical trials

MWV announces availability of preservative pharmaceutical spray pumps for sampling

FDA refuses Delcath's chemosaturation delivery system NDA filing

CARBOGEN AMCIS installs new stability chambers at Switzerland facility

Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolio

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Novavax announces final safety, immunogenicity results from H1N1 VLP vaccine at WHO meeting

China-Biotics applies 5 new patents for probiotics supplement, preparation

San Francisco area patient files DePuy hip replacement recall lawsuit

Inspire announces strategic corporate restructuring on its eye care business

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Spectranetics fourth quarter revenues decrease 1% to $29.3 million

Poll: 73% of New Jersey people think investment on global health research is important to state's economy

Avesthagen completes development of microalgae based vegetarian DHA omega 3 essential fatty acid

Astellas, AVEO enter development, commercialization agreement for tivozanib

Bruker introduces NPFLEX-LA non-contact, three-dimensional surface metrology system

BARDA awards contracts for development of drugs to treat injuries associated with acute radiation syndrome

Research: Plants may assist in detecting environmental contaminants, explosives

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy